GNOM - Global X Genomics & Biotechnology ETF

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
-0.05 (-0.35%)
At close: 2:04PM EDT
Stock chart is not supported by your current browser
Previous Close14.44
Bid0.00 x 3100
Ask0.00 x 800
Day's Range14.34 - 14.51
52 Week Range13.92 - 15.39
Avg. Volume23,372
Net AssetsN/A
PE Ratio (TTM)N/A
YTD ReturnN/A
Beta (3Y Monthly)0.00
Expense Ratio (net)0.68%
Inception Date2019-04-05
Trade prices are not sourced from all markets
  • ETF Trends11 days ago

    Four Companies Could Power The New Genomics ETF

    Earlier this week, the Global X Genomics & Biotechnology ETF (Nasdaq: GNOM) debuted, giving investors a new avenue for tapping the fast-growing genomics market. GNOM tracks the Solactive Genomics Index ...

  • ETF Trends15 days ago

    A New Biotech ETF For an Exciting Theme

    The biotechnology space is one of the most exciting and innovative corners of the broader healthcare sector. Some exchange traded funds (ETFs) reflect that innovation including a new fund Global X. The ...

  • Benzinga16 days ago

    Get In On Genomics With This New ETF

    Since the completion of the National Institutes of Health and Department of Energy-funded Human Genome Project in 2003, genomics has been one of the most compelling areas of the biotechnology universe. ...

  • ETF Trends16 days ago

    Global X Debuts Pure Play Genomics ETF ‘GNOM’

    Global X debuted a new fund on Tuesday that's among the first ETFs to explicitly track the genomics market with targeted, pure play exposure. The Global X Genomics & Biotechnology ETF (GNOM) becomes Global X's 13th fund in its Thematic Growth suite. The new ETF stands to benefit from advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.

  • PR Newswire17 days ago

    Global X Launches GNOM: An ETF targeting the Transformative Genomics Industry

    NEW YORK , April 9, 2019 /PRNewswire/ -- Global X ETFs, the New York -based provider of exchange-traded funds, announced today the launch of the 13 th fund in its Thematic Growth suite, the Global X Genomics ...